iMine Corporation announced that Dr. Carlos Rizo was appointed as a director by the company's sole director, Daniel Tsai. upon the election of Dr. Rizo, Daniel Tsai, the company's sole director and officer, resigned as director and officer. Dr. Carlos Rizo was appointed as chief executive officer, chief financial officer, president and secretary.

Dr. Rizo, age 48, has been the chief executive officer of Bwellmed International Holdings Ltd., a Canadian agri-pharma company with a wholly-owned subsidiary in Colombia which is licensed to product pharmaceutical grade, non-psychoactive cannabis products for medicinal, industrial and scientific purposes in Colombia which Dr. Rizo founded in 2016. Mr. Tsai did not resign because of a disagreement on any matter relating to the Company's operations, policies or practices.